March 1-6, 2016 – Belgium. As CEO of INCELL, 4RMED and TEKSA Innovations, Dr. Mary Pat Moyer will meet with fellow CEOs, leaders and directors of companies, innovative scientists and clinicians, investors, and economic development professionals interested in new company formation and growth or expansion of existing companies globally. Discussions and presentations will focus on actions to bring together disruptive technologies, business approaches and training for accelerating regenerative medicine therapies for clinical applications in the US, Europe and worldwide.
February 27-29, 2016-Belgium. In February 2016, Dr. Moyer met with Wisetree Investors and collaborators in the Bioturnkey Initiative, an innovative solution for manufacturing, accelerated product development, clinical, testing and new company support.